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A 2.2-kb cDNA that contains the entire coding region of mouse protein kinase c-19 (PKC-6’) was cloned from skeletal muscle mRNA using reverse 
transcription and the polymerase chain reaction (PCR). This clone was used as a probe to study the expression of this PKC isoform in normal 
and transformed hemopoietic cells and other normal tissues. By far the highest steady-state level of PKC-0 mRNA was found as a 2.8-kb transcript 
on a Northern blot of poly(A)’ RNA from testes. High levels were also found in skeletal muscle, spleen, T lymphomas and purified normal T 
lymphocytes, but these tissues and cells expressed two transcripts, 3.3 kb and 3.8 kb. Lower levels of similar size transcripts were found in normal 
brain, B lymphocytes and B-lymphocytic tumors and cell lines. 
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1. INTRODUCTION 
Protein kinase C (PKC) is a multi-gene family of at 
least nine serine/threonine kinases that are central to 
many signal transduction pathways [1,2]. cDNA clon- 
ing and sequencing studies have shown that eight of the 
PKCs are encoded by different genes, and one, PKC- 
/III, represents the product of alternative splicing of the 
same gene that encodes PKC-PI [3-g]. PKC is the major 
intracellular receptor for phorbol esters, which are po- 
tent activators for most of the isozymes and well known 
tumor promoters [9,10]. The physiological activator of 
PKC is thought to be SiV-1,2-diacylglycerol, produced 
as a lipophilic second messenger either from turnover 
of inositol phospholipids or phosphatidylcholine as a 
result of external stimulation by hormones, growth fac- 
tors, etc. [1,2]. A required cofactor is anionic phospho- 
lipid, preferably phosphatidylserine. Additionally, 
PKC-a, ;O and -y are dependent on the presence of Ca’+ 
for activation of their kinase activity [l-3], whereas 
PKC-8, -E, -q and -8 are Ca2’-independent [7,8,11,12]. 
The Ca”-independent isoforms, also referred to as 
novel or nPKCs, are activated by micelles composed of 
phosphatidylserine and diacylglycerol. Another mem- 
ber of the PKC gene family, PKC-[, does not bind 
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phorbol esters and is not activated by Ca2’ [6,13,14]. Its 
mechanism for activation is unknown. 
Most cells express several of the PKC isozymes, and 
most PKCs are found in a wide variety of cell types. The 
combination of isozymes that are expressed seem to be 
unique to each tissue. We have recently reported that 
the expression of PKC-a through -q in hemopoietic cells 
is cell type- and, at least for B lymphocytes, differentia- 
tion stage-specific [15]. Cell type- and differentiation 
stage-specific patterns of PKC isozyme expression have 
been reported for other cell lines and tissues [16-181. 
The cloning of an additional member of the PKC gene 
family, PKC-B [8], which appeared to be the principal 
isoform expressed in mouse skeletal muscle, prompted 
us to investigate its expression more thoroughly in dif- 
ferent mouse hemopoietic cell lines and tumors, as well 
as in normal tissues. During the preparation of this 
manuscript, a report appeared in which PKC-8 was 
shown to be abundantly expressed in hemopoietic cells 
1191. 
2. MATERIALS AND METHODS 
2.1. Cloning of mouse PKC-0 
1 pg of mRNA from BALB/c skeletal muscle was reverse tran- 
scribed using random hexamers and the Superscript kit (BRL) follow- 
ing the manufacturer’s protocol. 10 ng of cDNA were used in each 100 
~1 polymerase chain reaction (PCR) using Taq Polymerase (BRL or 
Perkin Elmer) or Vent DNA polymerase (New England Biolabs, Bev- 
erly, MA). The following primers used for PCR were taken from the 
sequence published for PKC-0 from mouse muscle [8]. For location 
of the primers in the published sequence the position of the final base 
of each primer is given in parentheses. GAATTCG- 
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CAAATCCCTTCCAGTCTGGA (2,161); GAATTCCGACAC- 
CAGGGAACAACC (-18). Each of the 30 cycles of PCR included 
1 min annealing at 58°C. 2 min extension at 72°C and 30 s denatura- 
tion at 94°C. The initial denaturing step lasted 3 min, and the final 
extension lasted 5 min. The reaction products were resolved on a 1% 
low-melting point agarose gel (BRL) and the expected bands were 
isolated as described [20]. 20 ng of the DNA fragment were 
phosphorylated using T4-kinase, ligated into 10 ng of SmaI-digested 
pBS (Stratagene), and the resulting DNA was transfected into electro- 
competent DHlOB cells (BRL) using electroporation. Positive colo- 
nies were identified by colony hybridization using the PCR fragment 
and confirmed by restriction digestion of DNA isolated from positive 
clones. 
2.2. Northern blor analysis 
Tissue, tumors, cell lines or purified normal T and B cells were 
obtained as described [15]. Poly(A)’ RNA was directly isolated from 
frozen cell pellets or pulverized tissue [2 11. 5 pg of mRNA was loaded 
onto each lane of 1% agarose gels containing formaldehyde, and 
electrophoretically resolved. The RNA was transferred to HybondmN 
membranes (Amersham) by capillary transfer, and the blots were 
probed with 3 x IO6 cpm per ml of a ‘*P-radiolabeled 1 .I-kb PstI 
fragment of glyceraldehyde-phosphate dehydrogenase (GAPDH, [22]) 
to normalize for mRNA content in each lane. Subsequently, the blot 
was stripped with boiling water and re-probed with a 2-kb I&RI 
fragment of mouse PKC-8 cDNA. For the detection of additional 
PKC transcripts, full-length cDNAs from mouse PKC-a [23], rat 
PKC$ and -y [3], mouse PKC-8 [ll], -E [24], -[ [14] and -7 [15] were 
used. 
3. RESULTS 
We decided to use PCR for cloning PKC-8 cDNA 
since this method, if successful, should be much faster 
than conventional cloning approaches. We obtained a 
2.2-kb DNA fragment that contained the entire protein- 
coding region using the two primers described. The 2.2- 
kb DNA fragment was cloned into PBS and identified 
as PKC-8 by restriction mapping and partial sequenc- 
ing (data not shown), both of which revealed 100% 
identity with the previously published mouse PKC-8 [8]. 
We first used the PKC-0 cDNA as a probe to investi- 
gate the expression of PKC-8 in different normal mouse 
tissues (Fig. 1). Two transcripts for PKC-8 of 3.3- and 
3.8-kb were found in easily detectable levels in skeletal 
muscle tissue and spleen, while very low levels of similar 
size transcripts were found in almost every other tissue 
examined. The 1.3-kb bands that are visible in several 
lanes of all figures represent remnants of GAPDH 
bands from a previous hybridization. The highest level 
of PKC-0 expression, however, was in testes, which 
revealed an mRNA of different size, ca. 2.8 kb. 
To investigate more thoroughly the expression of 
PKC-8 in hemopoietic cells, we probed Northern blots 
of an extensive set of mRNAs from 67 B-lymphocytic, 
9 T-lymphocytic and 9 myeloid tumors and cell lines 
(for a more detailed description of the cell lines see [1_5] 
and [25]), as well as normal B and T lymphocytes. 
Fig. 2 is a Northern blot of RNAs from a series of 
B-lymphocytic cell lines that vary from early progenitor 
B cells on the left through pre-B and B cells to plasma- 
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Fig. 1. Northern blot of 5 pg poly(A)’ RNA from normal mouse 
tissues probed with the 2.2-kb PKC-8 cDNA. The sizes (in kb) and 
positions of RNA markers are indicated on the left. Hybridization of 
the same blot with GAPDH is shown in the lower panel. 
cytomas on the right. PKC-8 is expressed as 3.3- and 
3.8-kb mRNAs in most of the B lymphocytic cell lines 
examined, but at variable, generally low levels that do 
not change significantly during B cell development. The 
presence of the occasional 1.8 and 4.8 kb bands is due 
to cross-reactivity with ribosomal RNA. Only two of 
the tumors, BAL 17, a B cell lymphoma, and ABPC 
103, a plasmacytoma, expressed PKC-8 in easily detect- 
able amounts. Generally the 3.3-kb mRNA predomi- 
nated over the larger form, and sometimes the 3.8-kb 
mRNA was not seen at all, e.g. SJL4. 
RNAs from 9 myeloid cell lines were examined (7 
examples are shown in Fig. 3) and no 3.3- or 3.8-bands 
of PKC-8 mRNA were detectable. 
In contrast, normal T lymphocytes and most T-cell 
lines express high levels of both 3.3- and 3.8-kb PKC-B 
mRNA (Fig. 4), as can be seen from our Northern blot 
analysis. Only BW 5147 and two clones obtained from 
cell fusions with BW 5 147, T5 and 2B4, failed to express 
detectable amounts of PKC-B mRNA. 
To study whether other members of the PKC-gene 
family are expressed as different size messages in testes, 
we probed Northern blots of poly(A)’ RNA from brain 
and testes with cDNA probes of all known PKC genes. 
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Fig. 2. Northern blot of 5 pg poly(A)+ RNA from different mouse 
B-lymphocytic cell lines in increasing degrees of maturation from left 
to right, and normal splenic B cells. The order of individual RNAs 
corresponds to the differentiation stage of the cells. HAFTL-1 (pro-B), 
NFS 112 and NFS 25 (pre-B), WEHI 231, BAL 17, and BAL 1131 
(mature B), SJL 4 (plasmablast) and ABPC 89, ABPC 103 and TEPC 
1173 (plasmacytomas). The sizes (in kb) and positions of RNA mark- 
ers are indicated on the left; an exposure of the same blot probed with 
GAPDH is shown below. 
As shown in Fig. 5, none of the Ca*+-dependent PKCs 
is expressed in detectable amounts in testes. Only PKC- 
6, -5 and -0 mRNAs can be easily detected in this tissue, 
and all three transcripts differ in size from the respective 
PKC mRNAs expressed in brain. 
4. DISCUSSION 
Our experiments demonstrate that under proper con- 
ditions, a > 2-kb cDNA can easily be cloned by using 
RT-PCR. In our hands, however, these results could 
only be obtained with Vent DNA polymerase. We were 
unable to amplify DNA fragments > 1 kb in our RT- 
PCR when we used Tag DNA polymerase. 
Our results confirm the previous report [8] that PKC- 
0 is expressed in quite high amounts in skeletal muscle 
tissue and in low, but easily detectable amounts in 
spleen, brain and heart. Unexpectedly, expression is 
highest not in skeletal muscle, but in testes, although we 
detected only one transcript of ca. 2.8 kb. Our probe is 
specific for the 8 isoform, because it does not detect any 
other PKC transcript under the high stringency condi- 
tions utilized, even in cells that over-express other PKC 
isozymes (data not shown). We also probed this blot 
with the mouse brain PKC-8 cDNA that was previously 
published [8], and found identical results (data not 
shown). The results reported here differ from those of 
Baier et al. [19], who used a ‘semi-quantitative PCR’ 
approach and could detect only very low levels of PKC- 
8 mRNA in human testes. We suspect that the discrep- 
ancy in results stems from the use of PCR with only one 
pair of primers on testes transcripts which, as indicated 
by our Northern blot data, are 500-1,000 bp shorter 
than those in any other tissue. Alternatively, man and 
mouse might differ in their PKC expression patterns. 
Testes express mRNAs of unusual size for a variety 
of genes [26], including other PKC genes. As shown in 
Fig. 5, only three of the eight known PKC genes are 
expressed at easily detectable levels in testes, and all 
three isoforms appear as transcripts that are different 
in size from those in brain. Transcripts of PKC-13 and 
-6 (the isotype most similar in structure to PKC-0) in 
testes are ca. 500 bp shorter than those in brain or any 
other tissue and are unique to testes ([11,15], and this 
manuscript). The 2.5-kb PKC-c transcript in testes is 
the same size as the lower molecular weight transcript 
seen in other tissues or cell lines [14,17], although most 
of them contain an additional 4.5-kb PKC-c mRNA, 
which is completely absent in testes. Brain is the unique 
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Fig. 3. Northern blot of 5 pug poly(A)’ RNA from different myeloid 
tumors (ABPL-2, ABPL-3, ABPL4, J2M2 and J3M7) and cell lines 
(32D and M 1). The sizes (in kb) and positions of RNA markers are 
indicated on the left. Hybridization of the same blot probed with 
GAPDH is shown below. 
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Fig. 4. Northern blot of 5pg poly(A)’ RNA from different T lympho- 
mas (LUT-13, LUT-14, P1798 and RBL 5), cell lines (EL-4, BW 5147 
and two hybridomas, T5 and 2B4). The last lane contains 5 pg 
poly(A)’ from normal CD4+ and CDB’ T cells that were purified from 
lymph nodes as described [15]. The sizes (in kb) and positions of RNA 
markers are indicated on the left; an exposure of the same blot probed 
with GAPDH is shown below. 
tissue in the case of PKC-c in that its transcripts are ca. 
200 bp smaller than those of testes or any other tissue. 
We previously examined the expression of PKC-cr. 
through -q in hemopoietic cells [15] and concluded that 
the patterns of expression of PKC isozymes are different 
for each cell type, and, in the case of B lymphocytes, 
also differentiation stage-specific. Expression of PKC-8 
also differs among hemopoietic cells. In all myeloid cell 
lines examined PKC-8 mRNA is absent, or at least 
below our detection limit, whereas most of the cell lines 
of the B-lymphocyte lineage show low-to-moderate lev- 
els of expression, as do normal splenic B lymphocytes. 
The steady-state levels of PKC-8 mRNA in T-lym- 
phocytic cell lines and normal lymph node T lympho- 
cytes was very high, approximately twice that seen in 
skeletal muscle. Curiously we did not find any PKC-8 
expression in the T-cell fusing line, BW 5147, or in the 
two hybridomas derived from it. BW 5147 has lost sev- 
eral chromosomes or portions thereof during mutation 
and selection, and it lacks expression of most PKC 
isozymes and several other unrelated genes ([1.5], J.F.M. 
unpublished). In fact, the only PKC isoform expressed 
in these lines is PKC-8 [15]. 
Our Northern blot results are generally similar to 
those obtained by RNase protection and RT-PCR 
methods on human tissues and tumors [19], however, 
the interpretation of Baier et al. [19] was that PKC-8 
was predominantly expressed in hemopoietic cells based 
on their results with mostly T-cell lines. Our results 
from a survey of 85 hemopoietic tumors and cell lines, 
as well as purified lymphocytes, suggests that PKC-6’ 
mRNA is rarely found in B lymphocytes or myeloid 
cells, but it is commonly expressed in T lymphomas and 
purified T lymphocytes. Still, the highest level of expres- 
sion was not in T lymphocytes nor in skeletal muscle but 
in testes, as determined by Northern blot analysis. 
Although conclusive data indicating that the different 
PKC isozymes play unique roles in mediating certain 
biological responses are still scarce, the tissue-specific 
pattern of PKC isozyme expression, such as that re- 
ported here for PKC-8, point in this direction. Over- 
Fig. 5. Northern blots of 5 pg poly(A)’ RNA from normal mouse brain and testes probed for the expression of eight different PKC genes as indicated 
on the top. The sizes (in kb) and positions of RNA markers are indicated on the left. 
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expression of PKC isozymes in cell lines that do not 
express particular isozymes (e.g. PKC-a, 6, -r and -0 
in BW 5147) might be a promising approach to study 
the effects of the different PKC isozymes in certain cells. 
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